Clinical Drug Experience Knowledgebase

Anemia, Aplastic (Phase 2)

Anemia, Sickle Cell (Phase 2)

Astrocytoma (Phase 2)

Atrophic Vaginitis (Phase 1)

Atrophy (Phase 1)

Bronchiolitis (Phase 2)

Bronchiolitis Obliterans (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Cardiomyopathies (Phase 3)

Cardiomyopathy, Hypertrophic (Phase 3)

Colorectal Neoplasms (Phase 2)

Communicable Diseases (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Disease (Phase 2)

Dyslipidemias (Phase 3)

End Stage Liver Disease (Phase 3)

Gastritis (Phase 3)

Glioblastoma (Phase 2)

Helicobacter Infections (Phase 3)

Hodgkin Disease (Phase 2)

Hypertrophy (Phase 3)

Infections (Phase 3)

Inflammation (Phase 3)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Liver Diseases (Phase 3)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Medulloblastoma (Phase 2)

Melanoma (Phase 2)

Metabolic Syndrome (Phase 3)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neoplasms, Second Primary (Phase 2)

Neuroblastoma (Phase 2)

Opioid-Related Disorders (Phase 2)

Osteoarthritis, Hip (Phase 3)

Pancreatic Neoplasms (Phase 3)

Parkinson Disease (Phase 3)

Peritoneal Neoplasms (Phase 2)

Pinealoma (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Renal Insufficiency (Phase 3)

Schizophrenia (Phase 4)

Sickle Cell Trait (Phase 2)

Syndrome (Phase 3)

Thymoma (Phase 2)

Thymus Neoplasms (Phase 2)

Vaginitis (Phase 1)